Answer
Agomelatine increases noradrenaline and dopamine release specifically in the frontal cortex, with no influence on extracellular serotonin levels.
Sources for this answer
- ValdoxanServier Laboratories Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 21Document updated
Sources checked